Navigation Links


HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience

3/5/2015
ARLINGTON, Va. , March 5, 2015   HX360 today announced that sixteen companies have been selected as semi-finalists in the HX360 Innovation Challenge competition. These companies, selected from a field of eighty-three entries, will compete to be chosen as one of four finalists to present their solutions live before a panel of senior health system executives and venture c... [Comments]

LifeCell Dx Offers New Option to Veterans with Infertility

3/5/2015
Buffalo, New York (PRWEB) March 05, 2015 LifeCell Dx and its founder, Dr. Lani Burkman want veterans to be able to get an Advanced Semen Analysis before they do anything else about infertility. Time, money, stress, blaming and guessing are all risk factors for struggling couples.Too often, the traditional path starts with assuming the woman is the source of the infertility. Infertility is f... [Comments]

American Phytopathological Society Announces Annual Meeting Daily Schedule

3/5/2015
St. Paul, Minn. (PRWEB) March 05, 2015 Plant disease specialists from around the world will meet in Pasadena this summer at the Annual Meeting of The American Phytopathological Society. Details of the program are starting to be released online now at APSnet.org/meet . The Preliminary Daily Schedule has just been announced for the meeting, to be held August 1-5, 2015 in Pasadena, Califo... [Comments]

BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm

3/5/2015
Altamonte Springs, FL (PRWEB) March 05, 2015 BioPlus Specialty Pharmacy (BioPlus) announces the hiring of Jamie Damm for the position of Vice President of Managed Care. In this role, Damm will build and support managed care relationships for one of the nation’s leading specialty pharmacies. Damm, who is based in Seattle, brings more than 15 years of specialty pharmacy and biotech experie... [Comments]

Established in Plants, Now Confirmed in Animals — Chromatin in Daughter Cells is Asymmetrical in All Eukaryotes

3/5/2015
IDAHO (PRWEB) March 05, 2015 Bi-Biomics today announced a discovery made possible through Ultralight Histology’s paraffin and stain additive. The improvement in histological quality provided the detail necessary to observe the binary features present in all daughter cells. After processing with Ultralight Histology’s novel FFPE protocol, chromatin packaging was analyzed at 1000-1600x usi... [Comments]

Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors

3/5/2015
Research Triangle Park, NC (PRWEB) March 05, 2015 North Carolina-based life sciences company Entegrion, Inc., announced that Pierre Noel, M.D., Professor of Medicine, Mayo Clinic College of Medicine, has been elected to the Company’s Board of Directors. Entegrion’s Executive Chairman John B. Mowell said, “We are extremely fortunate to have Dr. Noel, a distinguished physician and resear... [Comments]

Aptose Biosciences to Present at the 27th Annual ROTH Conference

3/5/2015
SAN DIEGO and TORONTO , March 5, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced that William G. Rice , Ph.D., Chairman, President and Chief Executive Officer, will present at the upcoming 27th Annual ROTH Conference on... [Comments]

OncoTherapy Network Highlights Kidney Cancer Awareness Month

3/5/2015
NORWALK, Conn. , March 5, 2015  UBM Medica US announces that OncoTherapy Network , a leading online community to help oncologists and other clinicians gain a better understanding of the newest information available regarding the use of targeted therapies and immunotherapies, highlights special coverage of kidney cancer. March is National Kidney Cancer Awareness Month... [Comments]

Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success

3/5/2015
DUBLIN , Mar. 05, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) has announced the addition of the "Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success" report to their offering. All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a posi... [Comments]

Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD")

3/5/2015
SAN DIEGO , March 5, 2015  In response to the incorrect assertions by LD, distributed by Marketwired in Miami, FL on February 12, 2015. Impeto Medical SAS and its U.S. company are both of strong financial health and their SUDOSCAN® devices have been proven to provide accurate results, as clinical research has indicated. Furthermore, Impeto prefers to have the... [Comments]

[next]
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
(Date:2/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ... "Global Biometrics Market (2014-2020): Market Forecast By Technologies, ... to their offering. , In ... is anticipated to overtake North America ... spending towards IT security, government biometric based projects ...
(Date:1/22/2015)... Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), ... general the State of Washington,s Department ... new enrollment and central issuance system for driver,s licenses and ... The project planning and development will start in January 2015, ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... neurotransmitter serotonin in the brain may also affect the ... understood, say scientists from Georgetown University Medical Center and ... found, for the first time, that serotonin is passed ... the chemical is specifically used to activate an immune ...
... have released a new variety of asparagus that offers ... and boasts an excellent spear quality, marked by a ... marketable spears reduces the impact of high land and ... raising consumer prices. , Named "DePaoli" after William ...
... $10.3 million to help develop a new prosthetic arm that would ... is a key part of a U.S. Department of Defense contract ... soldiers and potentially others whose arms were amputated. , "Imagine an ... allows you to feel both the outside world and your own ...
Cached Biology News:Commonly used antidepressants may also affect human immune system 2Commonly used antidepressants may also affect human immune system 3Researchers release new variety of asparagus 2Researchers release new variety of asparagus 3University of Utah to help build bionic arm 2University of Utah to help build bionic arm 3University of Utah to help build bionic arm 4University of Utah to help build bionic arm 5
...
... Adapted to Sf-900 II ... isolated from Spodoptera frugiperda ... cells (1). The Sf21 ... serum-free suspension culture in ...
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
... Clone/PAD: ZMD.473. Immunogen: Synthetic peptide ... the mouse junctophilin-2. Specificity: Specific ... Mouse (positive controls: mouse skeletal muscle ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: ...
Biology Products:
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... , 3.75% Convertible Senior Notes due May 1, ... per $1,000 principal amount or approximately $5.72 per share, effective ... note is adjusted in connection with the regular quarterly dividend ... stockholders who own shares of PDL on March 5, 2015, the ...
(Date:3/4/2015)... March 04, 2015 USDM Life ... the life sciences industry, hired David Blewitt ... Cloud Compliance Services and Solutions at USDM Life ... based applications while maintaining compliance with government regulations worldwide. ... been an accomplished life sciences regulatory and IS compliance ...
(Date:3/4/2015)... San Bruno, CA. (PRWEB) March 04, 2015 ... Organization (CRO) headquartered in the San Francisco Bay Area, ... Clinical Trials (OCT) Israel Conference 2015 on March ... PRC Clinical seeks to build relationships with Israeli life ... Administration (FDA) clinical trials. The company’s services span all ...
(Date:3/4/2015)... 2015 Vegalab announced the acquisition of Ecowin, ... year. As part of the acquisition, Ecowin rebranded itself ... his role as CEO for the company,s Korea operations. ... work alongside Koo and oversee developments at the new ... Koo founded Ecowin in 2008 to ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3
... 26 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN),a ... for the early,detection of diseases and personalized ... for the fourth quarter and year ended,December ... year for GeneNews because of the,advancements made ...
... a.m. EDT, NEW YORK and HAIKOU CITY, ... ("China Pharma") (OTC Bulletin Board: CPHI),which develops, manufactures, ... today announced it will release its,Fourth Quarter and ... In,conjunction, the Company will host an earnings conference ...
... Sales Teams Promoting a 5-ASA Medicine, ... Shire plc (LSE: SHP, NASDAQ: SHPGY), the ... agreement with,TAP Pharmaceutical Products Inc. for LIALDA(TM) ... of remission in patients with,active, mild to ...
Cached Biology Technology:GeneNews announces 2007 year end results 2GeneNews announces 2007 year end results 3GeneNews announces 2007 year end results 4GeneNews announces 2007 year end results 5GeneNews announces 2007 year end results 6GeneNews announces 2007 year end results 7GeneNews announces 2007 year end results 8GeneNews announces 2007 year end results 9GeneNews announces 2007 year end results 10China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results 2Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 2Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 3Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 4Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis 5